On Wednesday, in the course of current trade, Shares of Eli Lilly and Co (NYSE:LLY), dropped -2.90%, and is now trading at $86.15.
News Highlights
- Now for Android: Lilly Diabetes’ Glucagon Mobile App to support #diabetes caregivers
- Leverage the power of Android or iPhone technology through the Lilly Glucagon Mobile App for people with #diabetes
- Assist be prepared for a severe #diabetes low blood sugar episode with the Lilly Glucagon Mobile App for Android or iPhone
Lilly Diabetes has released an Android version of its mobile application designed for caregivers and healthcare providers who support people with diabetes. Through an injection tutorial and emergency instructions, the App can assist people practice the injection steps ahead of time, which may assist them feel better prepared to assist. Other features of the App comprise a kit location log, so kits can be easily located during an emergency, and an expiration date log that sends a reminder when a kit is getting close to its expiration date, so a new kit can be obtained before this date.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products.
During an Afternoon trade, Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), dipped -0.73%, and is now trading at $146.17.
BioMarin Pharmaceutical, declared that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, August 3, at 4:30 p.m. ET to talk about second quarter 2015 financial results and provide a general business update.
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally.
Finally, Marriott International Inc (NASDAQ:MAR) , lost -0.22% Wednesday, hitting its highest level.
JW Marriott Hotels & Resorts, the distinctive sophisticated brand of Marriott International (MAR), declares the debut of JW Marriott Los Cabos Beach Resort & Spa in Fall 2015. The 299-room luxury beachfront resort, designed by renowned architect Jim Olson in partnership with Mexico City-based design firm IDEA Asociados, is dedicated to cherishing and showcasing Los Cabos’ natural environment and traditions.
“A rich destination with a deep cultural narrative, our newest resort property will provide guests with first-hand luxury experiences and unpredictable discoveries in a captivating part of the world,” said Mitzi Gaskins, Vice President, Luxury Brand Administration & Guest Experience at Marriott International. “JW Marriott Los Cabos Beach Resort & Spa combines local flavor, world-class design by Jim Olson and JW Marriott’s signature service to offer an authentic and enriching experience to guests.”
Situated in the upscale Puerto Los Cabos community, JW Marriott Los Cabos Beach Resort & Spa resides amidst the desert dunes of Baja California Sur, Mexico, at the point where the Sea of Cortez and the Pacific Ocean converge to overlook the “aquarium of the world.” Upon entering the open-air lobby, guests will be right away greeted by the sea and the resort’s expansive infinity pools, creating the effect of the ocean merging with the property itself. The resort will boast well-designated guest rooms and suites – all with unobstructed ocean views – in addition to seven restaurants, a world-class spa & fitness center, beach club, banquet and meeting facilities, and retail shops. The resort’s architectural design will also provide idyllic spaces to display international works of contemporary art from renowned international artists.
Marriott International, Inc. operates, franchises, and licenses hotels and timeshare properties worldwide. It operates through three segments: North American Full-Service, North American Limited-Service, and International.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
